Successful treatment of a child with idiopathic multicentric Castleman disease associated with hemophagocytic lymphohistiocytosis using tocilizumab

Pediatr Blood Cancer. 2019 Jul;66(7):e27759. doi: 10.1002/pbc.27759. Epub 2019 Apr 15.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Castleman Disease* / complications
  • Castleman Disease* / diagnostic imaging
  • Castleman Disease* / drug therapy
  • Castleman Disease* / pathology
  • Child, Preschool
  • Humans
  • Lymphohistiocytosis, Hemophagocytic* / complications
  • Lymphohistiocytosis, Hemophagocytic* / diagnostic imaging
  • Lymphohistiocytosis, Hemophagocytic* / drug therapy
  • Lymphohistiocytosis, Hemophagocytic* / pathology
  • Male

Substances

  • Antibodies, Monoclonal, Humanized
  • tocilizumab

Supplementary concepts

  • Multi-centric Castleman's Disease